Indian pharmaceutical companies are stepping up their investments to tap growing opportunities in biosimilars in Europe and emerging markets.... ...http://smartinvestor.business-standard.com/market/Compnews-420867-Compnewsdet-Drug_companies_step_up_global_investments_to_tap_biosimilars.htm
/PRNewswire/ -- Research and Markets has announced the addition of the "Enbrel Biosimilars Clinical Trial & Opportunity Insight" report to their... ...http://in.advfn.com/news_Global-Enbrel-Biosimilars-Clinical-Trial-Opportu_72733580.html
/PRNewswire/ -- RnRMarketResearch.com adds "Depression - Pipeline Review, H2 2016" to its store. The report provides an overview of the... ...http://www.prnewswire.co.in/news-releases/pipeline-of-depression-market-covering-therapeutics-under-development-for-h2-2016-598144011.html
MUMBAI: RPG Life Sciences' net sales for the second quarter ended September 2016 stood at Rs 76.38 crore, a growth of 22%, while profit before tax... ...http://timesofindia.indiatimes.com/business/india-business/RPG-Life-Sciences-reports-22-growth-in-sales/articleshow/54985926.cms
Top 100 billionaires see their wealth rise 10%; top 20 account for half of total wealth of top 100. The top 20 billionaires in the Forbes India... ...http://www.rediff.com/money/report/brick-and-mortar-billionaires-back-on-forbes-rich-list/20161020.htm
we are leading traders...